US stock · Healthcare sector · Medical Distribution
Company Logo

AmerisourceBergen Corporation

ABCNYSE

156.79

USD
+2.30
(+1.49%)
Market Closed
18.75P/E
12Forward P/E
0.85P/E to S&P500
31.709BMarket CAP
0.89%Div Yield
Upcoming Earnings
2 May-8 May
Shares Short
1/13/23
3.32M
Short % of Float
2.33%
Short % of Shares Outs.
1.64%
% Held by Insiders
16.94%
% Held by Institutions
73.14%
Beta
0.54
PEG Ratio
1.80
52w. high/low
174.63/134.70
Avg. Daily Volume
1.65M
Return %
Stock
S&P 500
1 year
12.10
(8.58)
3 years
65.69
23.39
5 years
- -
- -
Scale: |
High
Low
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
102.00
69.36
94.75
70.55
111.25
72.06
135.26
94.89
174.63
127.94
169.16
154.19
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
Revenue per share
178.40
218.47
238.74
276.18
294.41
314.30
380.67
525.89
624.29
692.01
701.29
770.82
854.51
927.29
1,039.19
1,144.46
1,166.19
Earnings per share
1.27
0.78
1.67
2.26
2.59
2.84
1.88
1.22
(0.62)
6.73
1.67
7.61
4.07
(16.65)
7.48
8.15
8.34
FCF per share
2.94
1.87
2.12
3.27
3.67
4.51
2.53
5.27
16.94
12.79
4.75
4.93
9.68
8.97
10.82
10.59
7.67
Dividends per share
0.10
0.15
0.21
0.32
0.43
0.52
0.85
0.94
1.17
1.36
1.47
1.53
1.61
1.68
1.78
1.88
1.89
CAPEX per share
0.32
0.43
0.49
0.65
0.62
0.65
0.88
1.16
1.06
2.19
2.14
1.54
1.48
1.81
2.13
2.38
2.37
Book Value per sh.
8.37
8.44
9.04
10.47
10.52
9.71
10.04
8.61
2.91
10.03
9.45
13.46
13.70
(4.98)
1.08
(1.01)
0.77
Comm.Shares outs.
370
321
301
282
272
253
231
227
218
212
218
218
210
205
206
208
207
Avg. annual P/E ratio
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
11.5
20.4
(5.7)
15.7
18.3
18.7
P/E to S&P500
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.5
0.8
(0.1)
0.5
0.9
0.9
Avg. annual div. yield
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.7%
1.9%
1.8%
1.5%
1.3%
1.2%
Revenue (m)
66,074
70,190
71,760
77,954
80,218
79,490
87,959
119,569
135,962
146,850
153,144
167,940
179,589
189,894
213,989
238,587
241,805
Operating margin
1.2%
1.2%
1.2%
1.4%
1.5%
1.6%
1.0%
0.7%
0.3%
1.0%
0.7%
0.9%
0.6%
(2.7)%
1.1%
1.0%
1.0%
Depreciation (m)
104
96
94
104
126
147
171
193
250
392
432
510
498
408
515
710
630
Net profit (m)
469
251
503
637
707
719
434
276
(135)
1,428
364
1,658
855
(3,409)
1,540
1,699
1,729
Income tax rate
37.1%
38.4%
37.9%
38.0%
37.5%
39.1%
40.2%
57.8%
149.2%
(2.7)%
60.3%
(37.2)%
11.7%
35.8%
30.5%
23.7%
22.3%
Net profit margin
0.7%
0.4%
0.7%
0.8%
0.9%
0.9%
0.5%
0.2%
(0.1)%
1.0%
0.2%
1.0%
0.5%
(1.8)%
0.7%
0.7%
0.7%
Working capital (m)
857
502
474
842
363
(227)
(477)
(450)
(2,366)
(2,429)
(2,515)
(1,975)
(1,449)
(797)
(2,556)
(3,888)
(4,052)
Long-term debt (m)
1,227
1,187
1,177
1,343
973
1,447
1,397
1,996
3,493
3,594
3,430
4,159
4,034
3,618
6,384
4,632
4,656
Equity (m)
3,100
2,710
2,716
2,954
2,867
2,457
2,320
1,957
634
2,129
2,064
2,933
2,879
(1,019)
223
(212)
74
ROIC
10.7%
8.3%
13.3%
15.1%
18.3%
18.3%
12.4%
7.3%
(3.7)%
18.8%
5.0%
20.0%
10.8%
(32.3)%
10.7%
14.6%
13.8%
Return on capital
6.2%
4.4%
6.4%
7.6%
8.1%
8.2%
4.4%
3.5%
1.4%
4.6%
3.0%
3.8%
3.0%
(11.7)%
4.2%
4.3%
4.0%
Return on equity
15.1%
9.2%
18.5%
21.6%
24.6%
29.3%
18.7%
14.1%
(21.3)%
67.1%
17.7%
56.5%
29.7%
334.5%
689.5%
(803.0)%
2,351.1%
Plowback ratio
92.1%
80.6%
87.5%
85.8%
83.4%
81.5%
54.9%
22.4%
288.2%
79.8%
12.1%
79.9%
60.4%
110.1%
76.2%
76.5%
77.4%
Div.&Repurch./FCF
126.5%
107.5%
80.4%
60.7%
95.8%
113.5%
116.1%
80.8%
- -
94.1%
62.7%
90.4%
49.8%
- -
20.1%
39.7%
105.8%
Capital Structure
1 Feb · 2023 | Q1
All numbers in millions
Total liabilities
$ 57,833
Total assets
$ 57,907
Long-term debt
$ 4,656
Cash and equiv.
$ 1,692
Goodwill
$ 8,597
Retained earnings
$ 3,557
Common stock
204
Enterprise Value
$ 34,672
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
4,598
2,547
3,388
Receivables
14,335
18,389
18,625
Inventory
12,589
15,368
15,556
Other
1,534
447
810
Current assets
33,056
38,803
39,590
Acc. Payable
31,705
38,010
40,193
Debt due
501
300
1,070
Other
1,647
3,048
2,215
Current liabilities
33,853
41,359
43,478
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
11.50%
9.21%
12.05%
Cash flow
(0.97)%
24.96%
36.41%
Earnings
10.32%
(170.45)%
(193.88)%
Dividends
6.83%
4.17%
8.14%
Book value
(194.72)%
(113.47)%
(29.11)%
Insider Trading
Type
Shares
Date
Miller Redonda
Award
228
02/01/23
Nally Dennis M
Award
194
02/01/23
Collis Steven H
Exempt
10,499
01/17/23
Collis Steven H
Sale
10,499
01/17/23
Collis Steven H
Exempt
10,499
01/17/23
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2021
52,517
49,154
53,406
58,912
213,989
2022
59,629
57,719
60,065
61,174
238,587
2023
62,847
- -
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
1.82
2.11
1.42
2.13
7.48
2022
2.15
2.63
1.95
1.41
8.15
2023
2.35
- -
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
0.44
0.44
0.45
0.45
1.78
2022
0.48
0.47
0.47
0.46
1.88
2023
0.49
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Distribution
CEO:
Mr. Steven Collis
Full-time employees:
39,000
City:
Chesterbrook
Address:
1300 Morris Dr
IPO:
Dec 16, 1993
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Recent News
· 24 Jan, 2023 · The Wall Street Journal
· 29 Dec, 2022 · The Wall Street Journal
· 28 Dec, 2022 · The Wall Street Journal
· 2 Feb, 2022 · The Wall Street Journal
· 20 Jul, 2021 · The Wall Street Journal
· 26 Jun, 2021 · The Wall Street Journal
· 2 May, 2021 · The Wall Street Journal